Semler Scientific, Inc. (SMLR)
NASDAQ: SMLR · Real-Time Price · USD
36.14
+4.20 (13.15%)
At close: Jun 20, 2025, 4:00 PM
35.35
-0.79 (-2.19%)
Pre-market: Jun 23, 2025, 5:13 AM EDT
Semler Scientific Revenue
Semler Scientific had revenue of $8.84M in the quarter ending March 31, 2025, a decrease of -44.44%. This brings the company's revenue in the last twelve months to $49.23M, down -25.28% year-over-year. In the year 2024, Semler Scientific had annual revenue of $56.29M, down -17.44%.
Revenue (ttm)
$49.23M
Revenue Growth
-25.28%
P/S Ratio
5.80
Revenue / Employee
$623,114
Employees
79
Market Cap
639.67M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 56.29M | -11.89M | -17.44% |
Dec 31, 2023 | 68.18M | 11.50M | 20.28% |
Dec 31, 2022 | 56.69M | 3.66M | 6.90% |
Dec 31, 2021 | 53.03M | 14.42M | 37.36% |
Dec 31, 2020 | 38.60M | 5.84M | 17.81% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
SMLR News
- 2 days ago - Semler Scientific wants to hold 105,000 Bitcoin by 2027 - Invezz
- 3 days ago - Semler Scientific® Appoints Joe Burnett as Director of Bitcoin Strategy; Targets Owning at Least 10,000 Bitcoins by Year-End 2025 and 105,000 by Year-End 2027 - PRNewsWire
- 5 days ago - Wolf Haldenstein Adler Freeman & Herz LLP is investigating Semler Scientific Inc. - GlobeNewsWire
- 10 days ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Semler Scientific, Inc. (SMLR) And Encourages Shareholders to Reach Out - Accesswire
- 11 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Semler Scientific, Inc. (SMLR) and Encourages Shareholders to Learn More About the Investigation - Accesswire
- 12 days ago - Semler Scientific, Inc. (SMLR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Accesswire
- 13 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Semler Scientific, Inc. (SMLR) Shareholders to Inquire about Securities Investigation - Accesswire
- 14 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Semler Scientific, Inc. (SMLR) And Encourages Investors to Connect - Accesswire